• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The critical need for alternative antiretroviral formulations, and obstacles to their development.对抗逆转录病毒替代制剂的迫切需求及其研发障碍。
J Infect Dis. 2011 Sep 1;204(5):669-74. doi: 10.1093/infdis/jir370. Epub 2011 Jul 25.
2
Pharmacokinetics of an antiretroviral regimen in a patient unable to swallow solid oral dosage forms.无法吞咽固体口服剂型患者的抗逆转录病毒治疗方案的药代动力学
Am J Health Syst Pharm. 2016 Jun 1;73(11):750-4. doi: 10.2146/ajhp150861.
3
Stopping antiretroviral therapy: role for therapeutic drug monitoring.停止抗逆转录病毒治疗：治疗药物监测的作用。
AIDS. 2008 Jan 11;22(2):315-6. doi: 10.1097/QAD.0b013e3282f3054f.
4
Comment on "Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid".对《长期联合抗逆转录病毒疗法较高的中枢神经系统渗透有效性与脑脊液中更好的HIV-1病毒抑制相关》的评论
J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):e118-9. doi: 10.1097/QAI.0b013e3182809d9f.
5
Response to Calcagno comment on "Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid".对卡尔卡尼奥就《长期联合抗逆转录病毒疗法更高的中枢神经系统渗透有效性与脑脊液中更好的HIV-1病毒抑制相关》的评论的回应
J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):e14-5. doi: 10.1097/QAI.0b013e3182a82281.
6
Antiretroviral drug treatment of CNS HIV-1 infection.抗逆转录病毒药物治疗中枢神经系统 HIV-1 感染。
J Antimicrob Chemother. 2012 Feb;67(2):299-311. doi: 10.1093/jac/dkr492. Epub 2011 Dec 8.
7
Key Principles of Antiretroviral Pharmacology.抗逆转录病毒药理学的关键原则。
Infect Dis Clin North Am. 2019 Sep;33(3):787-805. doi: 10.1016/j.idc.2019.05.006.
8
Superior neurocognitive function is associated with central nervous system antiretroviral drug penetration only in regimens containing more than three antiretroviral agents.仅在包含三种以上抗逆转录病毒药物的治疗方案中，高级神经认知功能才与中枢神经系统抗逆转录病毒药物的渗透有关。
AIDS. 2011 Apr 24;25(7):1014-5. doi: 10.1097/QAD.0b013e3283454c74.
9
Administering antiretroviral medication through enteral tubes.通过肠内管给予抗逆转录病毒药物。
Am J Health Syst Pharm. 2013 Jun 15;70(12):1016-7. doi: 10.2146/ajhp120772.
10
Dosing antiretroviral medication when crossing time zones: a review.跨时区时抗逆转录病毒药物的给药：综述
AIDS. 2016 Jan;30(2):267-71. doi: 10.1097/QAD.0000000000000920.

引用本文的文献

1
Switching to Long-Acting Cabotegravir and Rilpivirine in Turkey: Perspectives from People Living with HIV in a Setting of Increasing HIV Incidence.在土耳其改用长效卡博特韦和rilpivirine：在艾滋病毒发病率不断上升的背景下，艾滋病毒感染者的观点。
Medicina (Kaunas). 2025 Jul 29;61(8):1373. doi: 10.3390/medicina61081373.
2
Receipt of long-acting injectable antiretroviral therapy among people with HIV in Southern US states: an assessment using electronic health records and claims data.美国南部各州艾滋病毒感染者长效注射抗逆转录病毒疗法的接受情况：一项使用电子健康记录和理赔数据的评估
AIDS Res Ther. 2025 Feb 1;22(1):9. doi: 10.1186/s12981-024-00690-9.
3
Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence Barriers.长效抗逆转录病毒疗法对存在依从性障碍的未得到病毒抑制的人类免疫缺陷病毒感染者的预期益处。
Open Forum Infect Dis. 2023 Jul 22;10(8):ofad390. doi: 10.1093/ofid/ofad390. eCollection 2023 Aug.
4
Safety and efficacy of long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection: a systematic review and meta-analysis protocol.长效肌内注射卡替拉韦和利匹韦林治疗人类免疫缺陷病毒 1 型感染成人的安全性和有效性：系统评价和荟萃分析方案。
BMJ Open. 2022 Dec 26;12(12):e063089. doi: 10.1136/bmjopen-2022-063089.
5
Patient-Reported Outcomes Through 1 Year of an HIV-1 Clinical Trial Evaluating Long-Acting Cabotegravir and Rilpivirine Administered Every 4 or 8 Weeks (ATLAS-2M).通过评估每 4 或 8 周给药的长效卡替拉韦和利匹韦林的 HIV-1 临床试验，患者报告结果在 1 年内的情况（ATLAS-2M）。
Patient. 2021 Nov;14(6):849-862. doi: 10.1007/s40271-021-00524-0. Epub 2021 May 31.
6
Lopinavir/ritonavir, a new galenic oral formulation from commercial solid form, fine-tuned by nuclear magnetic resonance spectroscopy.洛匹那韦/利托那韦，一种新型的商业固体形态口服制剂，经核磁共振光谱法微调。
Eur J Hosp Pharm. 2022 Sep;29(5):259-263. doi: 10.1136/ejhpharm-2020-002389. Epub 2020 Nov 19.
7
Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomes.大环肽三唑 HIV-1 灭活剂单独及在脂质体中的药代动力学稳定性。
J Pept Sci. 2019 Apr;25(4):e3155. doi: 10.1002/psc.3155. Epub 2019 Feb 27.
8
Universal antiretroviral regimens: thinking beyond one-pill-once-a-day.通用抗逆转录病毒治疗方案：超越每日一片的思考。
Curr Opin HIV AIDS. 2017 Jul;12(4):343-350. doi: 10.1097/COH.0000000000000374.
9
Peptide triazole inactivators of HIV-1: how do they work and what is their potential?HIV-1的肽基三唑失活剂：它们如何发挥作用以及有何潜力？
Future Med Chem. 2015;7(17):2305-10. doi: 10.4155/fmc.15.152. Epub 2015 Nov 24.
10
Macrocyclic Envelope Glycoprotein Antagonists that Irreversibly Inactivate HIV-1 before Host Cell Encounter.在宿主细胞接触前不可逆地使HIV-1失活的大环包膜糖蛋白拮抗剂。
J Med Chem. 2015 Sep 24;58(18):7603-8. doi: 10.1021/acs.jmedchem.5b00935. Epub 2015 Sep 11.

本文引用的文献

1
A randomized crossover study to determine relative bioequivalence of tenofovir, emtricitabine, and efavirenz (Atripla) fixed-dose combination tablet compared with a compounded oral liquid formulation derived from the tablet.一项随机交叉研究，以确定替诺福韦、恩曲他滨和依非韦伦（Atripla）固定剂量复方片剂与源自该片剂的复方口服液体制剂相比的相对生物等效性。
J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):e130-2. doi: 10.1097/qai.0b013e31820eefbe.
2
Interventions for treating oral mucositis for patients with cancer receiving treatment.针对接受治疗的癌症患者口腔黏膜炎的干预措施。
Cochrane Database Syst Rev. 2010 Aug 4;2010(8):CD001973. doi: 10.1002/14651858.CD001973.pub4.
3
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.成人 HIV 感染的抗逆转录病毒治疗：国际艾滋病协会-美国小组 2010 年的建议。
JAMA. 2010 Jul 21;304(3):321-33. doi: 10.1001/jama.2010.1004.
4
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.聚乙二醇干扰素 Alfa-2a 在 HIV-1 单感染参与者中的安全性、耐受性和抗逆转录病毒活性的机制：一项 II 期临床试验。
J Infect Dis. 2010 Jun 1;201(11):1686-96. doi: 10.1086/652420.
5
Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents.带硫酸盐末端配体的金纳米粒子作为抗 HIV 药物。
Bioorg Med Chem Lett. 2010 May 1;20(9):2718-21. doi: 10.1016/j.bmcl.2010.03.079. Epub 2010 Mar 25.
6
Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody.每周或每两周皮下注射 PRO 140（一种 CCR5 单克隆抗体）治疗抗 HIV-1 的活性。
J Infect Dis. 2010 May 15;201(10):1481-7. doi: 10.1086/652190.
7
Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics.纳米制剂抗逆转录病毒药物组合可延长 HIV-1 感染巨噬细胞中的药物释放和抗逆转录病毒反应：对神经艾滋病治疗的启示。
J Neuroimmune Pharmacol. 2010 Dec;5(4):592-601. doi: 10.1007/s11481-010-9198-7. Epub 2010 Mar 17.
8
Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulation.利匹韦林（TMC278）纳米混悬剂作为长效注射抗逆转录病毒制剂的药代动力学和处置。
Antimicrob Agents Chemother. 2010 May;54(5):2042-50. doi: 10.1128/AAC.01529-09. Epub 2010 Feb 16.
9
Progress on scaling up integrated services for sexual and reproductive health and HIV.性健康和生殖健康及艾滋病综合服务扩大规模方面的进展。
Bull World Health Organ. 2009 Nov;87(11):846-51. doi: 10.2471/blt.08.059279.
10
Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.早期抗逆转录病毒疗法可降低急性机会性感染患者的艾滋病进展/死亡风险：一项多中心随机策略试验。
PLoS One. 2009;4(5):e5575. doi: 10.1371/journal.pone.0005575. Epub 2009 May 18.

The critical need for alternative antiretroviral formulations, and obstacles to their development.

作者信息

Swindells Susan, Flexner Charles, Fletcher Courtney V, Jacobson Jeffrey M

机构信息

Departments of Internal Medicine and Pharmacy Practice, University of Nebraska Medical Center, Omaha, NE, USA.

出版信息

J Infect Dis. 2011 Sep 1;204(5):669-74. doi: 10.1093/infdis/jir370. Epub 2011 Jul 25.

DOI:10.1093/infdis/jir370
PMID:21788451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3156101/
Abstract
摘要